The Wayback Machine - http://web.archive.org/web/20260220230027/https://finance.yahoo.com/sectors/healthcare/
Healthcare
This sector includes biotechnology, pharmaceuticals, research services, home healthcare, hospitals, long-term-care facilities, and medical equipment and supplies. Also include pharmaceutical retailers and companies which provide health information services. Companies in this sector include AstraZeneca, Pfizer, and Roche Holding, Walgreens Boots Alliance, and Cerner Corp.
Market Cap
7.609T
Market Weight
9.69%
Industries
11
Companies
1136
Healthcare S&P 500 ^GSPC
Chart Range Bar
Loading chart for Healthcare

Day Return

Sector
0.19%
S&P 500
0.69%

YTD Return

Sector
5.16%
S&P 500
0.19%

1-Year Return

Sector
13.61%
S&P 500
12.46%

3-Year Return

Sector
21.62%
S&P 500
69.39%

5-Year Return

Sector
26.50%
S&P 500
78.24%

Note: Sector performance is calculated based on the previous closing price of all sector constituents

Industries in This Sector

Select an Industry for a Visual Breakdown

IndustryMarket WeightYTD Return
All Industries
100.00%
5.16%
Drug Manufacturers - General
42.27%
17.66%
Biotechnology
12.35%
2.26%
Medical Devices
11.42%
-0.80%
Diagnostics & Research
9.53%
-7.27%
Healthcare Plans
7.54%
-7.90%
Medical Instruments & Supplies
6.71%
-2.78%
Medical Distribution
3.29%
10.63%
Medical Care Facilities
3.20%
10.89%
Drug Manufacturers - Specialty & Generic
2.55%
1.22%
Health Information Services
1.14%
-37.88%
Pharmaceutical Retailers
0.00%
-15.45%

Note: Percentage % data on heatmap indicates Day Return

All Industries

Drug Manufacturers - General
-0.44%
Biotechnology
-0.06%
Medical Devices
0.39%
Diagnostics & Research
-0.86%
Healthcare Plans
-0.49%
Medical Instruments & Supplies
0.79%
Medical Distribution
0.84%
Medical Care Facilities
0.95%
Drug Manufacturers - Specialty & Generic
-1.23%
Health Information Services
0.08%
Pharmaceutical Retailers
1.29%

<= -3

-2

-1

0

1

2

>= 3

Largest Companies in This Sector

View More
Table View
Heatmap View
Name
Last Price
1Y Target Est.
Market Weight
Market Cap
Day Change %
YTD Return
Avg. Analyst Rating
1,009.52 1,211.21 13.10% 952.338B -1.34% -6.06%
Buy
242.49 232.50 8.04% 584.376B -1.79% +17.17%
Buy
224.81 248.29 5.47% 397.326B +0.21% -1.61%
Buy
122.26 124.89 4.20% 305.379B +0.33% +16.15%
Buy
290.00 364.62 3.61% 262.693B +0.02% -12.15%
Buy
374.75 347.00 2.78% 202.016B -0.20% +14.49%
Buy
112.21 133.39 2.69% 195.297B +0.02% -10.44%
Buy
510.93 666.46 2.64% 191.961B -0.81% -11.83%
Buy
151.40 155.41 2.58% 187.839B +0.19% +23.35%
Buy
504.05 611.82 2.46% 179.003B +0.90% -11.00%
Buy

Investing in the Healthcare Sector

Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds

ETF Opportunities

View More
Name
Last Price
Net Assets
Expense Ratio
YTD Return
156.82 40.98B 0.08% +1.30%
289.90 19.812B 0.09% +0.71%
174.39 8.534B 0.44% +3.33%
124.78 8.336B 0.35% +2.34%
100.45 4.621B 0.40% +3.13%

Mutual Fund Opportunities

View More
Name
Last Price
Net Assets
Expense Ratio
YTD Return
209.11 39.263B 0.32% +2.22%
88.17 39.263B 0.32% +2.23%
145.53 19.812B 0.09% +1.10%
11.18 15.226B 0.00% +0.66%
134.20 15.226B 0.00% +0.74%

Healthcare Research

View More

Discover the Latest Analyst and Technical Research for This Sector

  • Analyst Report: Bayer Aktiengesellschaft

    Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs (39% of total sales in 2024) as well as vitamins and other consumer healthcare products (13% of total). The firm's crop science business (49% of total) sells seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.

    Rating
    Price Target
     
  • Analyst Report: Tandem Diabetes Care, Inc.

    Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.

    Rating
    Price Target
     
  • Technical Assessment: Bullish in the Intermediate-Term

    On Wednesday, we talked about the relative strength of the iShares Latin America 40 ETF (ILF). Today, we will expand on that and check in on the short- and long-term charts. ILF started trading in 2001, with the ETF having an explosive advance from March 2003 until May 2008, rising from $6.50 to over $61. The hyperbolic move barely paused during the more-than five years, but we all know what happens to blow offs like that. ILF plunged to $20 by late 2008, rebounded to $55 by 2011, and has been mostly a disaster ever since. The ETF's final bear-market bottom occurred during the pandemic (2020), when price fell to $15.50. After rallying to the low $30s by June 2021, ILF traded in a sideways box until early this year. The ETF not only broke out of this bullish base, but (much more importantly) broke the long-term bear market trendline off the all-time high peak from 2008. ILF dropped to $20 during the April 2025 tariff tantrum and then slowly started to build momentum during the following months. The ETF closed at $29.66 on December 17 and ripped to $37 in a little over a month, peaking on January 29. In recent weeks, ILF appears to be tracing out a tight bullish flag, which is a fairly reliable continuation pattern. A breakout over the recent high just above $37 could open the door to a move to the mid-$40s, which represents chart resistance and a key Fibonacci retracement of the bear market. The volume during the advance since last April has been consistently above average during advancing days, which demonstrates institutional accumulation. (Mark Arbeter, CMT)

     
  • Daily – Vickers Top Insider Picks for 02/20/2026

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

     

From the Community

Healthcare News